Sometimes during an analysis of data, manufacturers will identify nonsensical or counterintuitive results. Recognizing that the data is somehow “off” is a first step. A second step is to call in someone like Dark Horse with remediation experience to investigate and ask the necessary questions, with a goal of identifying the source(s) of the issue. This client, an established biotech, was facing problematic data from performance of a new assay at its CDMO and needed assistance in tracking the problem(s) back to the source.
The client’s project was back on track and the CDMO was able to generate the additional comparability data, as requested by the FDA. Additionally, the manufacturer now had a greater in-depth understanding of the assay methodology and the client had an increased sense of confidence in their manufacturing partner. The CDMO was also now prepared to be able to explain the “why” the next time an assay yielded unexpected or undesired data.